Alimera Sciences(ALIM) - 2023 Q4 - Annual Results
Exhibit 99.1 FOR IMMEDIATE RELEASE Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results Q4 Net Revenues up 88% to 80.8 million vs. 2022 Increases 2024 Revenue Guidance ATLANTA, March 7, 2024 -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial res ...